• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名有过多次流产史的遗传性血管性水肿患者成功的妊娠结局:一份拟定的分娩计划。

Successful Pregnancy Outcome in a Hereditary Angioedema Patient With Previous Pregnancy Losses: A Proposed Delivery Plan.

作者信息

Satnarine Travis, Xavier de Almeida Alana, Gebbia Jennifer, Kleiner Gary, Gans Melissa

机构信息

Pediatrics, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, USA.

Allergy and Immunology, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, USA.

出版信息

Cureus. 2024 Feb 26;16(2):e54939. doi: 10.7759/cureus.54939. eCollection 2024 Feb.

DOI:10.7759/cureus.54939
PMID:38544619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967679/
Abstract

This case report underscores the effective implementation of a delivery plan for a pregnant patient, focusing on a successful case study where a cesarean section, preceded by the pre-treatment of intravenous plasma-derived C1 inhibitor, resulted in the delivery of a healthy baby. The proposed delivery plan offers a systematic approach to managing hereditary angioedema during pregnancy. It recommends opting for delivery at an academic center equipped with high-risk obstetric care, obstetric anesthesia, and a level 4 Neonatal Intensive Care Unit. The plan also emphasizes the importance of early admission at the onset of labor and delineates specific protocols for both vaginal and cesarean deliveries.

摘要

本病例报告强调了针对孕妇实施分娩计划的有效方法,重点介绍了一个成功的案例研究,即在静脉注射血浆源性C1抑制剂进行预处理后进行剖宫产,最终产下一名健康婴儿。所提出的分娩计划为孕期遗传性血管性水肿的管理提供了一种系统方法。它建议选择在配备高危产科护理、产科麻醉和四级新生儿重症监护病房的学术中心进行分娩。该计划还强调了分娩开始时尽早入院的重要性,并阐述了阴道分娩和剖宫产的具体方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05a/10967679/48e92ec35b22/cureus-0016-00000054939-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05a/10967679/48e92ec35b22/cureus-0016-00000054939-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c05a/10967679/48e92ec35b22/cureus-0016-00000054939-i01.jpg

相似文献

1
Successful Pregnancy Outcome in a Hereditary Angioedema Patient With Previous Pregnancy Losses: A Proposed Delivery Plan.一名有过多次流产史的遗传性血管性水肿患者成功的妊娠结局:一份拟定的分娩计划。
Cureus. 2024 Feb 26;16(2):e54939. doi: 10.7759/cureus.54939. eCollection 2024 Feb.
2
Hereditary Angioedema in Pregnancy: A Case Report and Review of Obstetric Anesthesia Management.妊娠性遗传性血管性水肿:病例报告及产科麻醉管理综述。
A A Pract. 2024 Sep 9;18(9):e01833. doi: 10.1213/XAA.0000000000001833. eCollection 2024 Sep 1.
3
Case report: Hereditary angioedema in pregnancy.病例报告:妊娠期遗传性血管性水肿
Obstet Med. 2021 Sep;14(3):177-180. doi: 10.1177/1753495X20958225. Epub 2020 Oct 7.
4
Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.遗传性血管性水肿患者妊娠和分娩的管理:C1 抑制剂缺乏症。
J Investig Allergol Clin Immunol. 2016;26(3):161-7. doi: 10.18176/jiaci.0037.
5
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.遗传性血管性水肿女性患者的妇科和产科管理国际共识和实用指南,病因是 C1 抑制剂缺乏。
J Allergy Clin Immunol. 2012 Feb;129(2):308-20. doi: 10.1016/j.jaci.2011.11.025. Epub 2011 Dec 24.
6
Short-term Prophylaxis for Delivery in Pregnant Women with Hereditary Angioedema with Normal C1-Inhibitor.遗传性血管性水肿孕妇正常 C1 抑制剂的短期分娩预防
Rev Bras Ginecol Obstet. 2020 Dec;42(12):845-848. doi: 10.1055/s-0040-1718955. Epub 2020 Dec 21.
7
Obstetric Anesthetic Management for Parturients with Hereditary Angioedema: A Case Report and Suggested Protocol.产妇遗传性血管性水肿的产科麻醉管理:病例报告和建议方案。
Pain Med. 2021 Aug 6;22(8):1878-1882. doi: 10.1093/pm/pnaa457.
8
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.妊娠期采用艾替班特和重组 C1 抑制剂治疗遗传性血管性水肿发作。
J Clin Immunol. 2018 Oct;38(7):810-815. doi: 10.1007/s10875-018-0553-4. Epub 2018 Oct 2.
9
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with exposure to plasma-derived C1-inhibitor.C1抑制剂缺乏所致遗传性血管性水肿女性的妊娠:ITACA队列研究中母亲和儿童暴露于血浆源性C1抑制剂的结局结果
Front Med (Lausanne). 2022 Sep 14;9:930403. doi: 10.3389/fmed.2022.930403. eCollection 2022.
10
Hereditary angioedema and pregnancy: successful management of recurrent and frequent attacks of angioedema with C1-inhibitor concentrate, danazol and tranexamic acid - a case report.遗传性血管性水肿与妊娠:应用C1抑制剂浓缩物、达那唑和氨甲环酸成功治疗复发性频繁发作的血管性水肿——病例报告
Obstet Med. 2009 Sep;2(3):123-5. doi: 10.1258/om.2009.090003. Epub 2009 Sep 1.

本文引用的文献

1
Safety of medications for hereditary angioedema during pregnancy and lactation.遗传性血管性水肿药物在妊娠和哺乳期的安全性。
Expert Opin Drug Saf. 2023 Jan;22(1):17-24. doi: 10.1080/14740338.2023.2177269. Epub 2023 Feb 15.
2
Hereditary Angioedema During Pregnancy: Considerations in Management.妊娠期遗传性血管性水肿:管理注意事项。
Immunol Allergy Clin North Am. 2023 Feb;43(1):145-157. doi: 10.1016/j.iac.2022.05.011. Epub 2022 Oct 28.
3
Clinical outcomes of hereditary angioedema on multiparous women.多产妇女遗传性血管性水肿的临床结局
J Cosmet Dermatol. 2022 Dec;21(12):7163-7169. doi: 10.1111/jocd.15438. Epub 2022 Oct 25.
4
Is Icatibant Safe for the Treatment of Hereditary Angioedema During Pregnancy?依卡替班特治疗妊娠期遗传性血管性水肿是否安全?
Curr Allergy Asthma Rep. 2022 Oct;22(10):135-140. doi: 10.1007/s11882-022-01040-3. Epub 2022 Aug 31.
5
Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor.遗传性血管性水肿且C1抑制剂正常患者的妊娠情况
Front Allergy. 2022 Feb 17;3:846968. doi: 10.3389/falgy.2022.846968. eCollection 2022.
6
Case report: Hereditary angioedema in pregnancy.病例报告:妊娠期遗传性血管性水肿
Obstet Med. 2021 Sep;14(3):177-180. doi: 10.1177/1753495X20958225. Epub 2020 Oct 7.
7
Hereditary Angioedema in Pregnancy.妊娠期遗传性血管性水肿
Obstet Gynecol Surv. 2021 Sep;76(9):566-574. doi: 10.1097/OGX.0000000000000941.
8
Hereditary angioedema: Special considerations in women.遗传性血管性水肿:女性的特殊考虑。
Allergy Asthma Proc. 2020 Nov 1;41(Suppl 1):S47-S50. doi: 10.2500/aap.2020.41.200077.
9
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.皮下注射C1抑制剂治疗遗传性血管性水肿女性患者的长期疗效和安全性:一项3期试验开放标签扩展研究的亚组分析
Allergy Asthma Clin Immunol. 2020 Feb 4;16:8. doi: 10.1186/s13223-020-0409-3. eCollection 2020.
10
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update.《遗传性血管性水肿管理的国际 WAO/EAACI 指南——2017 年修订版》。
Allergy. 2018 Aug;73(8):1575-1596. doi: 10.1111/all.13384. Epub 2018 Mar 12.